N
Neurogene Inc. (NGNE)
NGM – Real Time Price. Currency in USD
32.03
+1.62 (5.33%)
At close: Jun 26, 2026, 4:00 PM EDT
31.61
-0.42 (-1.31%)
After-hours: Jun 26, 2026, 7:28 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
32.03
+1.62 (5.33%)
At close: Jun 26, 2026, 4:00 PM EDT
31.61
-0.42 (-1.31%)
After-hours: Jun 26, 2026, 7:28 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 13.07 | 6.05 | 10 | |
| Quick ratio | 13.07 | 5.63 | 10 | |
| Debt to Equity | 0.04 | 0.30 | 9.0 | |
| Debt to Assets | 0.03 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | 925K | N/A | N/A |
| Gross Profit | -3M | -3M | -2M | -3M | -3M |
| Operating Income | -57M | -56M | -83M | -103M | -111M |
| Net Income | -55M | -36M | -75M | -90M | -99M |
| EBITDA | -53M | -52M | -79M | -100M | -107M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -36.19 | 1.0 |
| Next quarter | N/A | -38.16 | 1.0 |
| Current year | N/A | -31.47 | 1.0 |
| Next year | N/A | -0.28 | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -25.05 | -24.1 | -57.25 | 3.3 |
| Y/Y | 999 | -36.58 | -28.69 | -22.47 | 3.3 |
| 3y average | 632.67 | -30.97 | -43.67 | -13.89 | 3.3 |
| 5y average | 779.2 | -33.24 | -39.48 | -27.93 | 3.3 |
| Weighted average score | 3.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $124.2M significantly exceed its total debt $9.1M, ensuring strong financial flexibility
Total current assets $246.6M exceed Total current liabilities $18.9M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$26.4M limits the company's ability to reinvest or pay down debt